Intelligence Hub
Market analytics and operational performance indicators
144 - August 25, 2023
Rocket Lab officer Adam Spice to sell 61,377 vested RSU shares worth $353K.
Brief
Rocket Lab USA officer Adam C. Spice filed Form 144 to sell 61,377 common shares acquired via restricted stock vesting on August 22, 2023. The proposed sale on August 25, 2023, has an aggregate market value of $352,525, representing a tiny fraction of outstanding shares. This follows a prior sale of 66,582 shares in May 2023; no material adverse information is known.
Detailed Brief
Form 144 is a notice of proposed sale of restricted securities under Rule 144 by Rocket Lab USA, Inc. officer Adam C. Spice (likely COO). He intends to sell 61,377 common shares on or about August 25, 2023, via Fidelity Brokerage, with a market value of $352,524.94 based on NASDAQ pricing. Shares were acquired August 22, 2023, through vesting of restricted stock units as compensation from the issuer. Outstanding shares: 483,326,614, making this ~0.013% of total. Spice sold 66,582 shares on May 26, 2023, for $299,319. The filing certifies no undisclosed material adverse information regarding the company's operations. This is routine insider transaction for liquidity from equity compensation, common in growth-stage space firms like Rocket Lab amid ongoing share-based pay.
Key Telemetry
- • Adam Spice (Officer) to sell 61,377 common shares (~$352,525 value) on 8/25/2023.
- • Shares acquired 8/22/2023 via RSU vesting as compensation.
- • Prior sale: 66,582 shares on 5/26/2023 for $299,319.
- • Negligible impact: 0.013% of 483M outstanding shares.
- • No known material adverse info.
Impact Vector
Routine insider sale of vested RSUs poses no material concern for Rocket Lab investors; it's standard compensation liquidity with negligible dilution or ownership impact. No adverse signals as filer affirms no undisclosed negatives. Strategic irrelevance to Neutron/launch ops; monitor aggregate insider selling trends for sentiment, but isolated small sales are typical.